Skip to main content
. Author manuscript; available in PMC: 2014 Dec 4.
Published in final edited form as: Gynecol Oncol. 2009 Sep 18;115(3):349–353. doi: 10.1016/j.ygyno.2009.08.013

Table 2.

Univariate Cox Regression Analysis

Variable HR 95% CI p-value

BMI (kg/m2) 1.07 1.02, 1.12 <0.01

Age (yrs) 1.00 0.97, 1.03 0.87

XRT (no/yes) 0.99 0.51, 1.93 0.98

Prior bowel surgery/injury* (no/yes) 0.55 0.24, 1.23 0.14

Cancer treatment at time of perforation (no/yes) 1.82 0.92, 3.60 0.08

Disease site
 Cervical (reference) 0.87
 Uterine 0.74 0.24, 2.26
 Ovarian/primary peritoneal 1.09 0.50, 2.36
 Other 1.26 0.45, 3.54

Disease status
 NED (reference category) <0.01
 Progressive/stable 3.10 1.34, 7.21
 Newly diagnosed 1.13 0.41, 3.14

Abdominal pain (no/yes) 1.54 0.58, 4.07 0.38

Fever (no/yes) 1.64 0.83, 3.23 0.15

Nausea/vomiting (no/yes) 0.91 0.41, 2.01 0.82

Bowel movements
 Normal (reference) 0.96
 Abnormal 0.98 0.47, 2.05

WBC (per 1,000 WBCs/μL) 1.04 1.01, 1.07 0.02

HCO3 (per mEQ/L) 0.92 0.86, 1.00 0.04

Albumin (g/dL) 0.86 0.54, 1.37 0.52

APACHE II 1.20 1.12, 1.29 <0.01

Treatment of perforation
 Conservative (reference) 0.01
 Surgical 0.29 0.11, 0.76

Suspected perforation cause
 Iatrogenic (reference)§ 0.17
 Tumor 2.00 0.63, 6.36
 Unknown 1.74 0.65, 4.66
 Colitis/appendicitis/proctitis 0.56 0.13, 2.36

Location of perforation

 Small bowel (reference) 0.32
 Ascending/Transverse/Descending Colon 1.94 0.80, 4.72
 Sigmoid/Rectum 1.23 0.54, 2.79

Variables included in multivariate Cox regression analysis

*

Bowel surgery/injury at the time of most recent abdominal surgery prior to intestinal perforation

Abbreviations: BMI, body mass index; XRT, radiation therapy; WBC, white blood cells; HCO3, bicarbonate; NED, no evidence of disease.

§

Iatrogenic causes include those diagnosed within 2 weeks of after staging surgery, colonoscopy, or intraperitoneal catheter placement